These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16312429)

  • 1. In vitro activity of some beta-lactams in combination with dicloxacillin against Mycobacterium fortuitum.
    Fattorini L; Amicosante G; Fiorentino D; Franceschini N; Oratore A; Orefici G
    J Chemother; 1989 Jul; 1(4 Suppl):339-41. PubMed ID: 16312429
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative activity of beta-lactamase inhibitors combined with beta-lactams against antibiotic-resistant enterobacter.
    Tejedor-Junco MT; Gonzalez-Martin M; Lupiola PA; Santana OE; Lopez-Orge RH; Gonzalez-Lama Z
    J Chemother; 1989 Jul; 1(4 Suppl):346-8. PubMed ID: 16312432
    [No Abstract]   [Full Text] [Related]  

  • 3. The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
    Dinçer I; Ergin A; Kocagöz T
    Int J Antimicrob Agents; 2004 Apr; 23(4):408-11. PubMed ID: 15081094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta-lactam inhibitors of beta-lactamases in Mycobacterium].
    Galán JC
    Rev Esp Quimioter; 1998 Dec; 11(4):386-8. PubMed ID: 10336326
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and antimicrobial evaluation of 2 beta-chloromethyl-6 beta-carbamoylmethyl-penam-1,1-dioxide-3-carboxylic acid.
    Gaviraghi G; Perboni A; Tamburini B; Xerri L; Salvatori A; Spadoni G; Tarzia G
    Farmaco; 1996 Jul; 51(7):535-8. PubMed ID: 8765676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spirocyclopropyl beta-lactams as mechanism-based inhibitors of serine beta-lactamases. Synthesis by rhodium-catalyzed cyclopropanation of 6-diazopenicillanate sulfone.
    Sandanayaka VP; Prashad AS; Yang Y; Williamson RT; Lin YI; Mansour TS
    J Med Chem; 2003 Jun; 46(13):2569-71. PubMed ID: 12801220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evolution of resistance to beta-lactam inhibitors of beta-lactamases].
    Alóz JI
    Rev Esp Quimioter; 1998 Dec; 11(4):375-6. PubMed ID: 10336321
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problems in the detection of resistance to beta-lactam inhibitors of beta-lactamases in the laboratory].
    Castillo García FJ
    Rev Esp Quimioter; 1998 Dec; 11(4):372-4. PubMed ID: 10336320
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mechanisms of resistance to beta-lactam inhibitors of beta-lactamases].
    Blázquez J
    Rev Esp Quimioter; 1998 Dec; 11(4):368-9. PubMed ID: 10336318
    [No Abstract]   [Full Text] [Related]  

  • 10. [Mycobacterium fortuitum beta-lactamases: introduction to the problem and first experimental data on their purification and characterization].
    Fattorini L; Fiorentino D; Franceschini N; Amicosante G; Orefici G
    Ann Ist Super Sanita; 1987; 24(2):349-54. PubMed ID: 3502594
    [No Abstract]   [Full Text] [Related]  

  • 11. [Study of "in vitro" susceptibility of "Mycobacterium fortuitum" to aminoglycoside and beta-lactam antibiotics (author's transl)].
    Casal M; Rodriguez F
    Ann Microbiol (Paris); 1981; 132B(1):51-6. PubMed ID: 7305191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the longevity of the beta-lactam antibiotics and of antibiotic/beta-lactamase inhibitor combinations.
    Buynak JD
    Biochem Pharmacol; 2006 Mar; 71(7):930-40. PubMed ID: 16359643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum beta-lactamases and carbapenemases.
    Livermore DM; Mushtaq S; Warner M; Miossec C; Woodford N
    J Antimicrob Chemother; 2008 Nov; 62(5):1053-6. PubMed ID: 18689875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antimycobacterial activity of some heteroarylcarboxamidrazone derivatives.
    Billington DC; Coleman MD; Ibiabuo J; Lambert PA; Rathbone DL; Tims KJ
    Drug Des Discov; 1998 Oct; 15(4):269-75. PubMed ID: 10546071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase.
    Shahid M; Singhai M; Malik A; Shukla I; Khan HM; Shujatullah F; Tahira F
    J Antimicrob Chemother; 2007 Jul; 60(1):187-8. PubMed ID: 17491002
    [No Abstract]   [Full Text] [Related]  

  • 16. Activity of various drugs alone or in combination against Mycobacterium fortuitum.
    Santos A; Cremades R; Rodríguez JC; Garcia-Pachon E; Ruiz M; Royo G
    J Infect Chemother; 2010 Feb; 16(1):64-7. PubMed ID: 20063030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for sterilizing activity of antibiotic combinations in an acid model of rapidly growing mycobacteria during the stationary phase of growth.
    Cremades R; Santos A; Rodríguez JC; García-Pachón E; Ruiz M; Escribano I; Royo G
    Chemotherapy; 2009; 55(2):114-8. PubMed ID: 19155619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance profile of strains of Mycobacterium fortuitum isolated from clinical specimens.
    Santos DR; Lourenço MC; Coelho FS; Mello FC; Duarte RS
    J Bras Pneumol; 2016; 42(4):299-301. PubMed ID: 27832239
    [No Abstract]   [Full Text] [Related]  

  • 19. Pyrido-1,2-thiazines and their in vitro antibacterial evaluation.
    Malinka W; Gamian A; Redzicka A; Swiatek P
    Acta Pol Pharm; 2008; 65(1):71-4. PubMed ID: 18536176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sensitivity of Mycobacterium fortuitum by the broth microdilution method determining the inhibitory minimal concentration].
    Ferrá Salazar C; Ramírez Alvarez MM; Montoro Cardoso E; Jiménez Misas CA; Fundora M
    Rev Cubana Med Trop; 1992; 44(2):109-12. PubMed ID: 9768199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.